Stemirna Therapeutics, a Chinese biotech start-up focusing on RNA technology-based drug development, has raised nearly RMB100 million (US$14.16 million) in a serious A round of financing.
Chinese Biotech Start-Up Stemirna Therapeutics Raises $14M Series A Round comes originally from China Money Network. All Rights Reserved....
Warning: Use of undefined constant php - assumed 'php' (this will throw an Error in a future version of PHP) in /home/fintekas/public_html/wp-content/themes/colornews-child/template-parts/content-single.php on line 108
This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of